Cailly L; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Gruchet C; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Maitre E; Department of Hematology, CHU Cote de Nacre University Hospital Caen France. Guidez S; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Delwail V; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Systchenko T; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Moya N; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Sabirou F; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Levy A; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Bobin A; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Gardeney H; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Nsiala L; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Vonfeld M; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Chacon A; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Pichon A; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France. Bouyer S; Department of Biology, CHU La Miletrie University Hospital Poitiers France. Baslé C; Department of Biology, CHU La Miletrie University Hospital Poitiers France. Dindinnaud E; Department of Biology, CHU La Miletrie University Hospital Poitiers France. Chomel JC; Department of Biology, CHU La Miletrie University Hospital Poitiers France. Raimbault A; Department of Biology, CHU La Miletrie University Hospital Poitiers France. Borde-Mougenot F; Department of Oncology, CH Saintes Saintes France. TroussardX; Department of Hematology, CHU Cote de Nacre University Hospital Caen France. Tomowiak C; Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2023 May 16; Vol. 11 (5), pp. e7343. Date of Electronic Publication: 2023 May 16 (Print Publication: 2023).
Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.
Autorzy:
Atsou KM; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Rachet B; Inequalities in Cancer Outcomes Network, Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK. Cornet E; Registre régional des hémopathies malignes de Basse-Normandie, CHU Caen-Normandie, Caen, France. Chretien ML; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France.; CHU Dijon Bourgogne, Service d'Hématologie Clinique, Dijon, France. Rossi C; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France.; CHU Dijon Bourgogne, Service d'Hématologie Clinique, Dijon, France. Remontet L; Pôle Santé Publique, Service de Biostatistique - Bio-informatique, Hospices Civils de Lyon, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Université de Lyon, Université Lyon 1, CNRS, Villeurbanne, France. Roche L; Pôle Santé Publique, Service de Biostatistique - Bio-informatique, Hospices Civils de Lyon, Lyon, France.; UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Université de Lyon, Université Lyon 1, CNRS, Villeurbanne, France. Giorgi R; SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Hop Timone, BioSTIC, Biostatistique et Technologies de l'Information et de la, Communication, Aix Marseille Univ, APHM, INSERM, IRD, Marseille, France. Gauthier S; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Girard S; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Böckle J; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Wasse SK; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Rachou H; Registre des Hémopathies Malignes de Gironde, Institut Bergonié, Bordeaux, France.; EPICENE Team, Inserm U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France. Bouzid L; Registre des Hémopathies Malignes de Gironde, Institut Bergonié, Bordeaux, France.; EPICENE Team, Inserm U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France. Poncet JM; Registre régional des hémopathies malignes de Basse-Normandie, CHU Caen-Normandie, Caen, France. Orazio S; Registre des Hémopathies Malignes de Gironde, Institut Bergonié, Bordeaux, France.; EPICENE Team, Inserm U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France. Monnereau A; Registre des Hémopathies Malignes de Gironde, Institut Bergonié, Bordeaux, France.; EPICENE Team, Inserm U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France. TroussardX; Registre régional des hémopathies malignes de Basse-Normandie, CHU Caen-Normandie, Caen, France. Mounier M; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France. Maynadie M; Registre des Hémopathies Malignes de la Côte-d'Or, CHU de Dijon Bourgogne, Dijon, France.; UMR INSERM 1231, Université Bourgogne Franche-Comté, Dijon, France.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 8911-8923. Date of Electronic Publication: 2023 Jan 29.
Development of a distributed international patient data registry for hairy cell leukemia.
Autorzy:
Andritsos LA; Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA. Anghelina M; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA. Neal J; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Blachly JS; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Mathur P; Department of Research Information Technology, College of Medicine, The Ohio State University, Columbus, OH, USA. Lele O; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA. Dearden C; The Royal Marsden NHS Foundation Trust, London, UK. Iyengar S; The Royal Marsden NHS Foundation Trust, London, UK. Cross M; The Royal Marsden NHS Foundation Trust, London, UK. Zent CS; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Rogers KA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Epperla N; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Lozanski G; Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA. Oakes CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Kraut E; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Ruppert AS; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Zhao Q; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Bhat SA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. Forconi F; Cancer Sciences and Haematology Department, University of Southampton Hospital Trust, Southampton, UK. Banerji V; Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Research Institute in Oncology and Hematology, Winnipeg, Canada. Handunnetti S; Haematology Department, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. Tam CS; Haematology Department, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. Seymour JF; Haematology Department, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. Else M; The Institute of Cancer Research, London, UK. Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA. Saven A; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA. Call T; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Johnston JB; Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Research Institute in Oncology and Hematology, Winnipeg, Canada. Tiacci E; Department of Medicine and Surgery, Institute of Hematology, University and Hospital of Perugia, Perugia, Italy. TroussardX; Department of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France. Tallman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Dietrich S; Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany. Tadmor T; Hematology Division, Bnai Zion Medical Center and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. Gozzetti A; Department of Medicine, University of Siena Policlinico S Maria alle Scotte, Siena, Italy. Zinzani PL; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, IRCCS Azienda Ospedaliero-Universitaria di Bologna and Istituto di Ematologia 'Seràgnoli', Bologna, Italy. Robak T; Department of Hematology, Medical University of Lodz, Lodz, Poland. Quest G; Pathology and Molecular Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Canada. Demeter J; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary. Rai K; Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA. Fernandez SA; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA. Grever M; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3021-3031. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
